59 related articles for article (PubMed ID: 9163510)
1. Real time observation of binding of herpes simplex virus type 1 (HSV-1) to Vero cells and neutralization of HSV-1 by sulfonated human immunoglobulin.
Inoue K; Arai T; Aoyagi M
J Biochem; 1997 Apr; 121(4):633-6. PubMed ID: 9163510
[TBL] [Abstract][Full Text] [Related]
2. Real time observation of the binding of herpes simplex virus type 1 (HSV-1) to immobilized heparan sulfate and the neutralization of HSV-1 by sulfonated human immunoglobulin.
Inoue K; Arai T; Aoyagi M
J Biochem; 1996 Aug; 120(2):233-5. PubMed ID: 8889804
[TBL] [Abstract][Full Text] [Related]
3. Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera.
Luo Y; Xiong D; Li HH; Qiu SP; Lin CL; Chen Q; Huang CH; Yuan Q; Zhang J; Xia NS
Virol J; 2016 Mar; 13():44. PubMed ID: 26987753
[TBL] [Abstract][Full Text] [Related]
4. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
Cairns TM; Huang ZY; Gallagher JR; Lin Y; Lou H; Whitbeck JC; Wald A; Cohen GH; Eisenberg RJ
J Virol; 2015 Sep; 89(18):9213-31. PubMed ID: 26109729
[TBL] [Abstract][Full Text] [Related]
5. Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.
Blevins TP; Mitchell MC; Korom M; Wang H; Yu Y; Morrison LA; Belshe RB
PLoS One; 2015; 10(12):e0144738. PubMed ID: 26658766
[TBL] [Abstract][Full Text] [Related]
6. Development of the suppository form of human immunoglobulin preparation with high titers of antibodies to herpes simplex virus types 1 and 2 for the treatment of chronic forms of herpetic disease.
Lazarenko AA; Alimbarova LM; Mordvintseva EY; Barinsky IF
Vopr Virusol; 2017; 62(1):36-41. PubMed ID: 29323845
[TBL] [Abstract][Full Text] [Related]
7. Development of a high-throughput β-Gal-based neutralization assay for quantitation of herpes simplex virus-neutralizing antibodies in human samples.
Baccari A; Cooney M; Blevins TP; Morrison LA; Larson S; Skoberne M; Belshe RB; Flechtner JB; Long D
Vaccine; 2016 Jul; 34(33):3901-6. PubMed ID: 27265458
[TBL] [Abstract][Full Text] [Related]
8. HSV-1-Specific IgG Subclasses Distribution and Serum Neutralizing Activity in Alzheimer's Disease and in Mild Cognitive Impairment.
Agostini S; Mancuso R; Hernis A; Costa AS; Nemni R; Clerici M
J Alzheimers Dis; 2018; 63(1):131-138. PubMed ID: 29578484
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific polyclonal immune response?
Manian FA
Clin Infect Dis; 1994 Sep; 19(3):448-53. PubMed ID: 7811864
[TBL] [Abstract][Full Text] [Related]
10. Responses of herpes simplex virus type 1-infected cells to the presence of extracellular antibodies: gE-dependent glycoprotein capping and enhancement in cell-to-cell spread.
Rizvi SM; Raghavan M
J Virol; 2003 Jan; 77(1):701-8. PubMed ID: 12477873
[TBL] [Abstract][Full Text] [Related]
11. Immune Milk Suppresses Herpes Simplex Virus Type 1.
Masuzawa M; Masuzawa M; Arakawa N; Hamada Y; Tamauchi H; Morita M; Nishiyama S; Sato Y
J Nutr Sci Vitaminol (Tokyo); 2016; 62(1):67-70. PubMed ID: 27117854
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of herpes simplex virus in viral meningoencephalitis suspected cases using molecular and serological methods].
Akçali A; Ozkaya E; Yilmaz D; Uyar Y; Oncül O
Mikrobiyol Bul; 2008 Jul; 42(3):421-8. PubMed ID: 18822885
[TBL] [Abstract][Full Text] [Related]
13. A direct quantitative PCR-based measurement of herpes simplex virus susceptibility to antiviral drugs and neutralizing antibodies.
Virók DP; Eszik I; Mosolygó T; Önder K; Endrész V; Burián K
J Virol Methods; 2017 Apr; 242():46-52. PubMed ID: 28093274
[TBL] [Abstract][Full Text] [Related]
14. Linear Multiepitope (Glyco)peptides for Type-Specific Serology of Herpes Simplex Virus (HSV) Infections.
Risinger C; Sørensen KK; Jensen KJ; Olofsson S; Bergström T; Blixt O
ACS Infect Dis; 2017 May; 3(5):360-367. PubMed ID: 28238255
[TBL] [Abstract][Full Text] [Related]
15. Cloning and characterization of human recombinant antibody Fab fragments specific for types 1 and 2 herpes simplex virus.
Cattani P; Plaisant P; Manzara S; Capodicasa N; Burioni R; Rossolini GM; Satta G
New Microbiol; 1995 Apr; 18(2):135-42. PubMed ID: 7603340
[TBL] [Abstract][Full Text] [Related]
16. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.
Osorio Y; Ghiasi H
J Virol; 2005 Mar; 79(6):3297-308. PubMed ID: 15731224
[TBL] [Abstract][Full Text] [Related]
17. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism.
Gerber SI; Belval BJ; Herold BC
Virology; 1995 Dec; 214(1):29-39. PubMed ID: 8525631
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus microneutralization: a simplification of the test.
Stalder H; Oxman MN; Herrmann KL
J Infect Dis; 1975 Apr; 131(4):423-30. PubMed ID: 163870
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus type 1 shows multiple interactions with sulfonated compounds at binding, penetration, and cell-to-cell passage.
Aguilar JS; Held KS; Wagner EK
Virus Genes; 2007 Jun; 34(3):241-8. PubMed ID: 16927129
[TBL] [Abstract][Full Text] [Related]
20. Role of Microvesicles in the Spread of Herpes Simplex Virus 1 in Oligodendrocytic Cells.
Bello-Morales R; Praena B; de la Nuez C; Rejas MT; Guerra M; Galán-Ganga M; Izquierdo M; Calvo V; Krummenacher C; López-Guerrero JA
J Virol; 2018 May; 92(10):. PubMed ID: 29514899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
